Amneal Pharmaceuticals (AMRX) Debt Ratio (2017 - 2026)

Amneal Pharmaceuticals' Debt Ratio history runs 10 years deep, the most recent figure standing at 0.73 for Q1 2026.

• On a quarterly basis, Debt Ratio rose 12.11% year-over-year to 0.73 in Q1 2026; TTM through Mar 2026 was 0.73, a 12.11% increase from a year earlier, with the FY2025 full-year figure at 0.7, down 5.96% from the prior year.
• Debt Ratio rose to 0.73 in Q1 2026 per AMRX's latest filing, from 0.7 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.75 in Q2 2024 and bottomed at 0.02 in Q3 2022.
• The 5-year median for Debt Ratio is 0.71 (2023), against an average of 0.63.
• Across the five-year window, Debt Ratio soared 4008.0% in 2022 and slipped 8.18% in 2025, its largest moves.
• Year by year, Debt Ratio stood at 0.69 in 2022, then increased by 8.46% to 0.75 in 2023, then slipped by 0.4% to 0.75 in 2024, then dropped by 5.96% to 0.7 in 2025, then increased by 3.87% to 0.73 in 2026.
• Per Business Quant, the three latest AMRX Debt Ratio figures stand at 0.73 (Q1 2026), 0.7 (Q4 2025), and 0.72 (Q3 2025).